Stockholders' Equity (Details) - Schedule of additional information about the stock option plans - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of additional information about the stock option plans [Abstract]
Number of Shares, Non-vested stock options as of January 1, 2021 (in Shares)	248,000
Weighted Average Fair Value at Grant Date, Non-vested stock options as of January 1, 2021	$ 3.25
Weighted Average Exercise Price, Non-vested stock options as of January 1, 2021	$ 6.44
Number of Shares, Non-vested stock options as of December 31, 2021 (in Shares)	160,000	248,000
Weighted Average Fair Value at Grant Date, Non-vested stock options as of December 31, 2021	$ 3.36	$ 3.25
Weighted Average Exercise Price, Non-vested stock options as of December 31, 2021	$ 7.23	6.44
Number of Shares, Stock options granted during the nine-month period ended December 31, 2021 (in Shares)	86,000
Weighted Average Fair Value at Grant Date, Stock options granted during the nine-month period ended December 31, 2021	$ 4.51
Weighted Average Exercise Price, Stock options granted during the nine-month period ended December 31, 2021	$ 9.78	5.03
Number of Shares, Stock options that vested during the nine-month period ended December 31, 2021 (in Shares)	147,000
Weighted Average Fair Value at Grant Date, Stock options that vested during the nine-month period ended December 31, 2021	$ 3.74
Weighted Average Exercise Price, Stock options that vested during the nine-month period ended December 31, 2021	$ 7.33
Number of Shares, Stock options that were forfeited during the nine-month period ended December 31, 2021 (in Shares)	32,000
Weighted Average Fair Value at Grant Date, Stock options that were forfeited during the nine-month period ended December 31, 2021	$ 3.81
Weighted Average Exercise Price, Stock options that were forfeited during the nine-month period ended December 31, 2021	$ 7.26	$ 5.45